S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 1 - Systemic treatment

Alexander Nast¹, Lasse Amelunxen², Matthias Augustin³, Wolf-Henning Boehncke⁴, Corinna Dressler¹, Matthew Gaskins¹, Peter Härle⁵, Bernd Hoffstadt⁶, Joachim Klaus⁷, Joachim Koza⁷, Ulrich Mrowietz⁸, Hans-Michael Ockenfels⁹, Sandra Philipp¹⁰, Kristian Reich¹¹, Thomas Rosenbach¹², Berthold Rzany¹³, Martin Schlaeger¹⁴, Gerhard Schmid-Ott¹⁵, Michael Sebastian¹⁶, Ralph von Kiedrowski¹⁷, Tobias Weberschock¹⁸

Affiliations

¹ Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology und Allergy, Division of Evidence-Based Medicine (dEBM).
² Fachklinik Bad Bentheim [Bad Bentheim Specialist Hospital].
³ Universitätsklinikum Hamburg-Eppendorf, Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen [University Hospital Hamburg-Eppendorf, Institute for Health Care Research in Dermatology and Nursing].
⁴ Service de Dermatologie et Vénéréologie, Hôpitaux Universitaires de Genève [Dermatology and Venereology Service, Geneva University Hospitals].
⁵ Katholisches Klinikum Mainz, Zentrum für Rheumatologische Akutdiagnostik, Klinik für Rheumatologie, Klinische Immunologie und Physikalische Therapie [Catholic Medical Center Mainz, Center for Rheumatological Diagnostics, Department of Rheumatology, ClinicaI Immunology and Physical Therapy].
⁶ Selbsthilfegemeinschaft Haut e. V. [Skin self-help association].
⁷ Deutscher Psoriasis Bund e. V. [German Psoriasis Society].
⁸ Psoriasis-Zentrum, Klinik für Dermatologie, Venerologie, Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel [Psoriasis Center, Department of Dermatology, Venereology and Allergology, University Hospital Schleswig-Holstein Kiel campus].
⁹ Haut- und Allergieklinik, Klinikum Hanau [Department of Dermatology and Allergology, Hanau Medical Center].
¹⁰ Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology und Allergy, Psoriasisstudienzentrum [Psoriasis Study Center].
¹¹ Dermatologikum Hamburg [Dermatologikum Hamburg].
¹² Niedergelassener Dermatologe, Osnabrück [Office-based Dermatologist, Osnabrück].
¹³ Privatpraxis Rzany & Hund, Berlin [Office-based Dermatologists Rzany & Hund, Berlin].
¹⁴ Niedergelassener Dermatologe, Oldenburg [Office-based Dermatologist, Osnabrück].
¹⁵ Berolina Klinik, Löhne [Berolina Medical Center, Löhne].
¹⁶ Niedergelassener Dermatologe, Mahlow [Office-based Dermatologist, Mahlow].
¹⁷ Niedergelassener Dermatologe, Selters [Office-based Dermatologist, Selters].
¹⁸ Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Frankfurt, Frankfurt/Main und Arbeitsgruppe EbM Frankfurt, Institut für Allgemeinmedizin, Goethe-Universität Frankfurt, Frankfurt/Main [Department of Dermatology, Venereology and Allergology, Frankfurt University Hospital, Frankfurt/Main and EbM Frankfurt working group, Institute for General Medicine, Goethe University Frankfurt, Frankfurt/Main].

PMID: 29750443
DOI: 10.1111/ddg.13516

S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 1 - Systemic treatment

Alexander Nast et al. J Dtsch Dermatol Ges. 2018 May.

. 2018 May;16(5):645-669.

doi: 10.1111/ddg.13516.

Authors

Affiliations

¹ Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology und Allergy, Division of Evidence-Based Medicine (dEBM).
² Fachklinik Bad Bentheim [Bad Bentheim Specialist Hospital].
³ Universitätsklinikum Hamburg-Eppendorf, Institut für Versorgungsforschung in der Dermatologie und bei Pflegeberufen [University Hospital Hamburg-Eppendorf, Institute for Health Care Research in Dermatology and Nursing].
⁴ Service de Dermatologie et Vénéréologie, Hôpitaux Universitaires de Genève [Dermatology and Venereology Service, Geneva University Hospitals].
⁵ Katholisches Klinikum Mainz, Zentrum für Rheumatologische Akutdiagnostik, Klinik für Rheumatologie, Klinische Immunologie und Physikalische Therapie [Catholic Medical Center Mainz, Center for Rheumatological Diagnostics, Department of Rheumatology, ClinicaI Immunology and Physical Therapy].
⁶ Selbsthilfegemeinschaft Haut e. V. [Skin self-help association].
⁷ Deutscher Psoriasis Bund e. V. [German Psoriasis Society].
⁸ Psoriasis-Zentrum, Klinik für Dermatologie, Venerologie, Allergologie, Universitätsklinikum Schleswig-Holstein, Campus Kiel [Psoriasis Center, Department of Dermatology, Venereology and Allergology, University Hospital Schleswig-Holstein Kiel campus].
⁹ Haut- und Allergieklinik, Klinikum Hanau [Department of Dermatology and Allergology, Hanau Medical Center].
¹⁰ Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venereology und Allergy, Psoriasisstudienzentrum [Psoriasis Study Center].
¹¹ Dermatologikum Hamburg [Dermatologikum Hamburg].
¹² Niedergelassener Dermatologe, Osnabrück [Office-based Dermatologist, Osnabrück].
¹³ Privatpraxis Rzany & Hund, Berlin [Office-based Dermatologists Rzany & Hund, Berlin].
¹⁴ Niedergelassener Dermatologe, Oldenburg [Office-based Dermatologist, Osnabrück].
¹⁵ Berolina Klinik, Löhne [Berolina Medical Center, Löhne].
¹⁶ Niedergelassener Dermatologe, Mahlow [Office-based Dermatologist, Mahlow].
¹⁷ Niedergelassener Dermatologe, Selters [Office-based Dermatologist, Selters].
¹⁸ Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Frankfurt, Frankfurt/Main und Arbeitsgruppe EbM Frankfurt, Institut für Allgemeinmedizin, Goethe-Universität Frankfurt, Frankfurt/Main [Department of Dermatology, Venereology and Allergology, Frankfurt University Hospital, Frankfurt/Main and EbM Frankfurt working group, Institute for General Medicine, Goethe University Frankfurt, Frankfurt/Main].

PMID: 29750443
DOI: 10.1111/ddg.13516

Abstract

The German guideline for the treatment of psoriasis vulgaris was updated using GRADE methodology. The guideline is based on a systematic literature review completed on December 1, 2016, and on a formal consensus and approval process. The first section of this short version of the guideline covers systemic treatment options considered relevant by the expert panel and approved in Germany at the time of the consensus conference (acitretin, adalimumab, apremilast, cyclosporine, etanercept, fumaric acid esters, infliximab, methotrexate, secukinumab and ustekinumab). Detailed information is provided on the management and monitoring of the included treatment options.

PubMed Disclaimer

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 1 - Systemic treatment

Affiliations

S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 1 - Systemic treatment

Authors

Affiliations

Abstract

MeSH terms

LinkOut - more resources

Full Text Sources